At Flare Capital, we do more than simply provide capital for early stage and emerging growth healthcare technology companies.

Venture Capital

Flare Capital

Co-Founders & General Partners

Marcus Wallace

Bob Sheehy offers a seasoned perspective on healthcare technology and leadership. Bob is a co-founder and CEO of Bright Health, a next generation healthcare payer and [Flare Capital](/org/flare-capital) portfolio company. Bob is the former CEO of UnitedHealthcare, where he worked for more than 20 years. Bob led all of UnitedHealthcare’s acquisitions that were health plan focused during a period of tremendous corporate growth. Previously, he served as president and chief operating officer of UnitedHealthcare and senior vice president of [UnitedHealth Group](/org/unitedhealth-group).

Bob Sheehy

Thomas Mac Mahon delivers deep healthcare-focused operational and financial insight, and has served on numerous private and public company boards. Previously, he was the CEO of Laboratory Group. His experience centers on financial reporting, accounting and controls, mergers and acquisitions, corporate finance, cost control and restructuring, operations, public policy, law and compliance, government regulation and information services. He was CEO Laboratory Group of America Holdings, senior vice president of Hoffmann-La Roche Inc., and president of Roche Diagnostics Group. He holds a B.S. in marketing from St. Peter’s College and an MBA from [Fairleigh Dickinson University](/org/fairleigh-dickinson-university).

Tom Mac Mahon

D. Scott Nordlund

Isaac Kohane, MD, PhD is the inaugural Chair of the Department of Biomedical Informatics at Harvard Medical School. He develops and applies computational techniques to address disease at multiple scales: From whole healthcare systems as “living laboratories” to the functional genomics of neurodevelopment with a focus on autism. Kohane’s i2b2 project is currently deployed internationally to over 120 major academic health centers to drive discovery research in disease and pharmacovigilance (including providing evidence on drugs which ultimately contributed to “black box”ing by the FDA). Dr. Kohane has published several hundred papers in the medical literature and authored a widely used book on Microarrays for an Integrative Genomics. He is a member of the Institute of Medicine and the American Society for Clinical Investigation.

Isaac Kohane

Gary Gottlieb is a professor of psychiatry at Harvard Medical School and a member of the National Academy of Medicine. From 2015 through June of 2019, he served as CEO of [Partners In Health](/org/partners-in-health), a global NGO providing a preferential option for the poor in health care in severely resource constrained settings. He assumed this role after serving on the PIH Board of Directors for a decade.

From 2010 until February of 2015, Dr. Gottlieb was the CEO of Partners HealthCare, the parent of the Brigham and Women’s and Massachusetts General Hospitals, the largest health care delivery organization in New England and among the largest biomedical research and training enterprises in the US. From 2002-2009, he was president of Brigham and Women’s Hospital. He also served as President of North Shore Medical Center and as Chair of Partners Psychiatry and Mental Health System. Dr. Gottlieb also served as a member of the Board of Directors of the [Federal Reserve Bank of Boston](/org/federal-reserve-bank-of-boston) from 2012-2016 and as its chair from 2016-2018.

Prior to coming to Boston, Dr. Gottlieb spent 15 years in positions of increasing leadership in health care in Philadelphia. He established the University of Pennsylvania Medical Center’s first program in geriatric psychiatry and developed it into a nationally recognized research, training, and clinical program. He served as executive vice-chair of psychiatry and associate dean for managed care at the University of Pennsylvania Medical Center, and as director and CEO of Friends Hospital, the nation’s first freestanding psychiatric hospital.

Gary Gottlieb

Dan is a Partner at [Flare Capital](/org/flare-capital) Partners, where he sits on the Board of [Somatus](/org/somatus), a [Flare Capital](/org/flare-capital) portfolio company. Dan also serves on Massachusetts Governor Charlie Baker’s Board of Nursing Home Administrators. Dan was a practicing Internal Medicine Physician at the Massachusetts General Hospital and had a Faculty appointment as Instructor in Medicine at Harvard Medical School from 2010 until 2019.

Prior to joining [Flare Capital](/org/flare-capital), Dan served as a Medical Director at the Harvard Pilgrim Health Plan, leading Population Health Analytics, Value Based Purchasing, and General Strategy. Dan also spent time as an entrepreneur and operator in the Health IT Industry, cofounding and managing two separate businesses in the Electronic Health Records and Online Medical Education industries.

Dan’s other interests include Healthcare Policy and Global Health. He has served as a Senior Health Policy Advisor for the Campaigns of Governor Charlie Baker and Congressman Joseph Kennedy III. He has worked to expand healthcare infrastructure in the developing world, serving as a consultant for the Clinton Foundation Health Access Initiative (CHAI) in Ethiopia.

Dan Gebremedhin

Adam joined [Flare Capital](/org/flare-capital) in 2017 and is responsible for finance, operations and administration.

Prior to joining [Flare Capital](/org/flare-capital) Partners, Adam spent over 14 years at [Advanced Technology Ventures](/org/atv), serving as its Chief Financial Officer since 2008.  Additionally, since its inception, Adam served as the Chief Financial Officer of Lightstone Ventures, an early stage Life Sciences venture capital fund founded in 2012 by partners from [Advanced Technology Ventures](/org/atv) and Morgenthaler Ventures.  In these roles, Adam was responsible for the financial matters, human resources and operations associated with both firms.  Prior to his career in venture, Adam was an investment banker in the Mergers and Acquisitions group of Donaldson, Lufkin & Jenrette and later with Credit Suisse First Boston.  While at DLJ and CSFB, Adam concentrated on financial sponsor transactions as well as corporate engagements. In addition, he supported the M&A group’s business development efforts, driving new engagements from both corporate and financial acquirers.  Prior to this, Adam was an Associate for Georgeson, Inc. (later acquired by Thomson Financial), where he advised technology companies, predominately in the semiconductor industry, on various aspects of their equity capital markets strategy.

Adam Bruce

Prior to joining [Flare Capital](/org/flare-capital), Ian served as a Senior Vice President and a founding member of [CareAllies](/org/careallies-llc), [Cigna](/org/cigna-corporation)’s family of multi-payer provider services, population health management, and home-based care businesses. In that capacity, he was responsible for developing new technology-enabled services, evolving existing solution and service lines, and providing ongoing product management across [CareAllies](/org/careallies-llc)’ businesses. In addition, he was also responsible for developing inorganic strategies for [CareAllies](/org/careallies-llc) since its inception. Before launching [CareAllies](/org/careallies-llc), Ian held a leadership position with [Cigna](/org/cigna-corporation)’s US Strategic Operations team.

Ian was a cofounder of several start-ups, including XcelDx which ultimately partnered with [Scanwell Health](/org/scanwell-health), a smartphone-enabled diagnostics company backed by Y-Combinator, [Founders Fund](/org/founders-fund), DCM, Version One, and [Mayfield](/org/mayfield). He focused his efforts on product development and serves as an advisor to the company. He also worked for Becton, Dickinson & Company where he led new product innovation and development. He continues to actively advise and mentor a number of innovative healthcare start-ups.

He started his career at [McKinsey & Company](/org/mckinsey-company) and spent five years advising healthcare clients globally.

Ian has a Bachelor of Science degree in biological engineering from [Cornell University](/org/cornell-university), where he graduated with honors and was a Cornell Presidential Research Scholar. He also holds an MBA from [Harvard Business School](/org/harvard-business-school).

Ian Chiang

Margaret is a Principal at Flare Capital Partners.

Margaret was a member of the deal team for Flare’s investment into BeMe Health, Cayaba Care, Eden Health, Elektra Health, and Oshi Health. In addition, she led the firm’s Flare Scholar Ventures investments into Darby, Docent, Frame Fertility, and Visana Health.

Before joining Flare Capital, Margaret partnered with entrepreneurs and investors to build executive teams and create the foundational human capital strategy for early-stage healthcare companies while at Oxeon Partners. Margaret also brings experience in healthcare-focused venture capital through her prior roles at 7wire Ventures and B Capital Group.

Margaret began her career as a clinical operations consultant with Huron Consulting Group’s healthcare practice. At Huron, she helped some of the nation’s leading academic medical centers adapt to changes in the industry through performance improvement initiatives resulting in a higher quality of patient care, greater interdisciplinary collaboration, and improved reimbursement. In addition to supporting her clients, she served as a leader of the care management methodology team who synthesized healthcare policy to create new solutions to improve patient status management, resource utilization, and discharge planning.

Margaret obtained her B.A. from Vanderbilt University with a major in Medicine, Health, and Society. She earned her M.B.A. from the University of Chicago Booth School of Business. While completing her M.B.A., Margaret was a Flare Capital Scholar. At the University of Chicago, she received the Madelon L. & Richard N. Rosett Merit Scholarship and the Hyde Park Angels Venture Capital Award.

Margaret is a co-founder of Dropping Claims, a content platform powered by the HealthTech Grind, a community of 300+ women entrepreneurs, operators, and investors passionate about healthtech.

Margaret Gaby Malone

Previously, Michael was the founding General Partner of [Flybridge](/org/flybridge) Capital Partners where he led the firm’s healthcare investments. Current and prior board seats include [Aspen RxHealth](/org/aspen-rxhealth), BlueTarp Financial, Circulation, Explorys, Functional Neuromodulation, [HealthVerity](/org/healthverity), higi, [Iora Health](/org/iora-health), MicroCHIPS, Nuvesse, PolyRemedy, Predictive Biosciences, Predilytics, [T2 Biosystems](/org/t2-biosystems), [TARIS Biomedical](/org/taris-biomedical), VidSys and [Welltok](/org/welltok) (observer). Additionally, Michael served on the board of International Data Group, the founding partner of [IDG Capital](/org/idg-capital), a leading venture capital fund in China and other important innovation centers in Asia.

Prior to [Flybridge](/org/flybridge), Michael focused on emerging-growth company financings with [Polaris Partners](/org/polaris-partners), was a senior vice president and founding partner of GCC Investments, and held positions at Wasserstein Perella & Co., Morgan Stanley & Co., and Credit Suisse First Boston.

Michael Greeley

Stanley Lapidus

Phyllis Gotlib was the co-founder and CEO of iMDsoft, a disruptive clinical information technology company that created innovative market-leading solutions to streamline and optimize hospitals’ high-acuity care. Ms. Gotlib led iMDsoft from inception through its exponential international growth and ultimately to its acquisition by TPG Growth in 2012. Prior to iMDsoft, she founded PS Gluck, a lucrative diamond trade company which she managed for many years with her partner in the Israeli Diamond Exchange (IDE). After her departure from PS Gluck, Phyllis joined Tactic Capital Markets (TCM), a boutique investment firm, as a managing partner. In TCM, Phyllis began to focus on healthcare investments.

Phyllis Gotlib

Prior to joining Flare Capital, Vic was a Product Strategy Manager at naviHealth, responsible for enterprise product strategy during the integration of legacy naviHealth, Curaspan and RightCare businesses. Vic joined naviHealth by way of Curaspan, where he worked on their successful strategic sale to naviHealth, a [Cardinal Health](/org/cardinal-health) company.

Previously, Vic was a manager at [McKinsey & Company](/org/mckinsey-company) serving healthcare providers. He focused primarily on health system strategy within the context of the Affordable Care Act and the transition to value-based care models. He helped build the Objective Health new venture, a tech-enabled consulting model for small to mid-sized health systems that is now a part of McKinsey’s Healthcare practice.  Out of college, he worked at PricewaterhouseCoopers in their Health Industries Advisory Practice, focusing on operational improvement, revenue cycle, and personalized medicine.  He also helped launch and served as the President and Executive Board Chair of Boston Young Healthcare Professionals, a 501(c)(3) organization aimed at providing educational, networking and community service opportunities for young healthcare professionals in Boston.

​Vic obtained his B.S. from [Boston College](/org/boston-college), with majors in Physics and Finance. He also obtained his M.B.A. from the MIT Sloan School of Management. While completing his M.B.A., he worked concurrently with Curaspan, Wellframe and was a Flare Capital Scholar. He also co-Directed the inaugural MIT Healthcare Innovations Prize, a pitch competition for health tech entrepreneurs in Boston.

Vic Lanio

Varsha Rao

Juan Lopez

Lawrence Cho

Aaron Foster is a financial advisor at [Flare Capital](/org/flare-capital). Aaron has over 20 years of experience in the industry, starting their career as a statistician intern at [Bristol-Myers Squibb](/org/bristol-myers-squibb) in 1996. Aaron then spent three years as a manager at [KPMG](/org/kpmg), where they provided economic consulting services. In 2003, they joined [Pfizer](/org/pfizer) as a financial analyst, where they worked for 17 years before joining [Flare Capital](/org/flare-capital) in 2020.

Dr. Aaron Foster is a biostatistician who earned their Doctor of Science from [Harvard University](/org/harvard). Aaron also holds a Bachelor of Science in Mathematics from [Morehouse College](/org/morehouse-college).

Aaron Foster

Chris Hocevar is an experienced senior healthcare executive and investor with over 25 years of experience. He currently serves as the Senior Healthcare Advisor for a large private equity investment firm. Chris is the former President of Cigna’s US Business Segments and Specialty Businesses where he worked for over 16 years during a period of rapid growth.

Chris Hocevar

Kelly is a Controller at Flare Capital Partners.

Kelly joined Flare Capital in 2022 and is responsible for supporting the CFO with finance and operations.

Prior to joining Flare, Kelly worked in the tax sector of public accounting for five years. After graduating from Northeastern in 2017, she started her career in New York at RSM on their Financial Services Tax team. There she focused primarily on the tax compliance for large hedge fund and private equity engagements. In 2020, Kelly started a new position at PwC in their Asset Wealth Management group. It was there that she was introduced to the venture capital space. She focused on the tax compliance for large venture capital engagements, and more specifically dealt with the transaction analysis to determine the tax implications of various deals. Kelly was promoted to manager at PwC prior to joining Flare.

Kelly earned her B.S.B.A. with concentrations in Finance and Accounting from Northeastern University’s D’Amore McKim School of Business.

Kelly Scherrer

During Bill’s more than twenty-year tenure investing in young and emerging healthcare technology companies, he has served on the Boards of numerous industry-leading companies and played a critical role, actively helping and working closely with founders and management. His current firm’s healthcare investments include [Aetion](/org/aetion), Bright Health, [ClearDATA](/org/cleardata), Curisium, [HealthReveal](/org/healthreveal), Intauleca, Valence Health (Evolent Health), and VisitPay.

Prior to [Flare Capital](/org/flare-capital), Bill was at North Bridge Venture Partners since its inception in 1994. Previously, Bill was a Partner at Hambro International Equity Partners. Prior to that, he was Chief Financial Officer at MathSoft, a science and engineering applications software start-up that went public on the NASDAQ and was later acquired by a leading design and product lifecycle software solutions company, and was a CPA at Arthur Andersen & Company.

Bill Geary

Parth is a Principal at [Flare Capital](/org/flare-capital) Partners.

Prior to joining [Flare Capital](/org/flare-capital), Parth was an investor at NewYork-Presbyterian (NYP) Ventures, responsible for venture investing, commercializing internal innovation and forming strategic partnerships to enhance the hospital’s patient and clinician care experience. At NYP, Parth primarily focused on applications of artificial intelligence to healthcare operations, leading the investment process for NYP’s investments in [Saykara](/org/saykara), [Syllable](/org/syllable) and Workfusion.

Prior to joining NYP Ventures, Parth was a health care strategy consultant at [Deloitte](/org/deloitte) Consulting, responsible for developing corporate growth strategies, performing M&A due diligence and supporting operational transformations for leading providers, payers and technology companies. At [Deloitte](/org/deloitte), he supported the creation of a tech-enabled managed services organization and a population health joint venture, while also advising a number of successful M&A transactions.

Parth began his career as health policy analyst for the Massachusetts House of Representatives, where he primarily worked with the Patrick administration to manage reform of the pharmaceutical compounding industry, authoring legislation signed into law by Governor Deval Patrick and used by the FDA to model national regulations.

​Parth earned his B.S. in Biology from [Boston College](/org/boston-college), MPH in Health Policy and Management from Boston University School of Public Health and Masters in Medicine from [Boston University School of Medicine](/org/boston-university-school-of-medicine).

Parth Desai

As Chief Executive Officer of Boston Children’s Hospital, Sandra L. Fenwick leads the nation’s foremost independent pediatric hospital and the world’s leading center of pediatric medical and health research.

Ms. Fenwick has been a driving force to improve the effectiveness and efficacy of the care provided at Boston Children’s while at the same time reducing the costs of care. Through a combination of hospital affiliations, outpatient specialty care centers, community health centers and regional partnerships, she has helped create a children’s health network across the Northeast, providing high quality pediatric care in local settings. She has also expanded its commitment to and investment in both basic, translational and clinical research, care, technology and delivery innovations and as well as prevention efforts focused on asthma, obesity and mental health. She is a tireless advocate for children’s health and has been instrumental in developing strategies that position Boston Children’s as the scientific and thought leader in pediatric health.

Sandra L. Fenwick

Susan Nelson

Jeffrey Graff

Seth Van Essendelft

Jen Barrera

Chris Churchill

Jolynn Suko

Mark Schroeder

Alaa Halawa

Todd Hofheins

Sreekanth Chaguturu

Stefan A. Strein

Alice Pope

Umesh joined [Tufts Health Plan](/org/tufts-health-plan) in 2008 as chief financial officer. He is responsible for the financial management of the corporation including financial planning and reporting, M&A, tax, treasury, procurement, audit, reserves, and actuarial and underwriting. He also oversees corporate strategy and business development activities.

Prior to [Tufts Health Plan](/org/tufts-health-plan), Umesh served as chief financial officer of Munich Re Health America, a leading provider of health care risk management solutions. Umesh has also served in senior leadership roles at CIGNA Corporation, including vice president of business development for the Asia/Pacific unit of CIGNA International, assistant vice president of provider and international strategy, and assistant vice president and controller of managed care operations. Umesh began his health care career at [Kaiser Permanente](/org/kaiser-permanente) in California and worked on both financing and delivery of health care.

Umesh Kurpad

Timothy Howe is a Senior Director in [Cox Enterprises](/org/cox-enterprises)’ Strategy and Corporate Development group, where he leads [Cox Enterprises](/org/cox-enterprises)’ Healthcare Strategy and leads Cox’s efforts to further develop the entrepreneurial ecosystem in Atlanta.

Prior to joining Cox in 2016, Tim was an executive at the General Electric Company focused on business operations and corporate development. Half of his 15 year career with GE was spent outside of the US.  More recently Tim led business integration and process simplification globally as the Process Excellence Leader for GE’s Distributed Power, which generated more than $5 billion in revenues annually. Tim spent three years as Managing Director and Integration Leader for GE’s Global Growth and Operations in China, responsible for joint venture portfolio management, strategy and M&A. Before moving to China, Tim was the Global Strategy and Channel Partner Development Leader for [GE Healthcare](/org/ge-healthcare-limited)’s eHealth Solutions start-up.

Timothy Howe

Scott is responsible for strategy, innovation and long-range strategic planning and business development activities, including mergers, acquisitions and strategic partnerships.

A national strategic thought leader, Scott has served at Advocate Health Care for 25 years and has held a number of business development and strategy positions during his tenure, including Vice President Business Development for Lutheran General Hospital, Vice President Business Development for Advocate Medical Group, and Vice President System Strategy and Development.

Prior to joining Advocate, he served as head of international sales and strategy for a medical device manufacturer.

Scott Powder

Nickolas Mark is a Managing Director and Partner at Intermountain Ventures where he focuses on investments, new ventures and strategic partnerships.

He is passionate about partnering with creative entrepreneurs, organizations, and investors to build successful businesses that drive meaningful, measurable and positive change across healthcare.

Nickolas has expertise in venture capital, entrepreneurship, corporate development, growth strategy, mergers, acquisitions, and divestitures. He has held leadership positions in a variety of organizations and industries. Previously, he served as a director for an investment management firm currently managing over $20 billion in assets. Prior to that, Nickolas held leadership positions at several leading advisory firms where he was instrumental in helping global organizations and fortune 500 companies with M&A, new ventures, growth strategies and the execution of transformational initiatives.

Nickolas Mark

Joseph C. Kvedar, MD, is creating a new model of healthcare delivery, developing innovative strategies to move care from the hospital or doctor’s office into the day-to-day lives of patients. He is the author of The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan (2017) and The Internet of Healthy Things (2015), describing how everyday objects will capture and use real-time biometric data to ultimately change behavior to improve our health.  He also authors the popular cHealth Blog where he writes about a myriad of topics on Connected Health, the intersection of Technology and Aging, Healthtech and much more.

Joseph Kvedar

Christopher Cleary

Bruce D. Broussard, President and CEO, joined Humana in 2011. Under his leadership, Humana has created an integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member experience. With its holistic approach, Humana is dedicated to improving the health of the communities it serves by making it easy for people to achieve their best health.

Bruce Broussard

Brenton Burns is Executive Vice President for [UPMC](/org/upmc) Enterprises. In this role, Brent is responsible for leading, developing and executing on [UPMC](/org/upmc) Enterprises’ strategy, commercialization efforts and portfolio management.

Prior to [UPMC](/org/upmc), Brent was Corporate Head of Business Development at [Anthem](/org/anthem) as well as Managing Director for HealthyCare Solutions.  In these roles, Brent was responsible for developing and executing on the company’s strategy (particularly around provider collaboration and services, consumer centricity, and data & analytics) as well as leading the HealthyCare Solutions platform.  Prior to WellPoint, Brent served as Senior Vice President – Strategy, Product Management, Business Development and Marketing for [McKesson](/org/mckesson). In this role, he was responsible for leading strategic planning and commercialization processes, product and project management, marketing, business development, acquisitions, and organic growth initiatives. Preceding this role, Burns served various roles in the [McKesson](/org/mckesson) Corporate Strategy and Business Development group.

Partners

Team members

Other teams at Flare Capital

Board of Directors

Leadership Team

CEO and Executive Team

Discover similar companies